Holdings Channel
Bill Ackman's: Pershing Square Capital Management
Louis Bacon's: Moore Capital Management
Kyle Bass's: HAYMAN CAPITAL MANAGEMENT,
Bruce Berkowitz's: Fairholme Capital Management
Warren Buffett's: Berkshire Hathaway
Steven Cohen's: Point72 Asset Management
Chase Coleman's: Tiger Global Management
Ray Dalio's: Bridgewater Associates
David Einhorn's: Greenlight Capital
Ken Fisher's: Fisher Asset Management
Jeremy Grantham's: Grantham Mayo Van Otterloo
Joel Greenblatt's: Gotham Asset Management
Ken Griffin's: Citadel Advisors
Andreas Halvorsen's: Viking Global Investors
Carl Icahn: Icahn Carl C
Seth Klarman's: Baupost Group
Daniel Loeb's: Third Point
Howard Marks's: Oaktree Capital Management
Victor Mashaal's: Senvest Management
John Paulson's: Paulson & CO.
Nelson Peltz's: Trian Fund Management
Larry Robbins's: Glenview Capital Management
Wilbur Ross's: Invesco Private Capital,
Barry Rosenstein's: Jana Partners
Jim Simons's: Renaissance Technologies
Paul Singer's: Elliott Investment Management
George Soros's: Soros Fund Management
Brian Taylor's: Pine River Capital Management
David Tepper's: APPALOOSA MANAGEMENT
Prem Watsa's: Fairfax Financial Holdings
Cathie Wood's: ARK Investment Management
Warren Buffett Dividend Stock Portfolio

Funds Holding BRIDGEBIOPHARMAINC

On this page, we present all of the funds holding BRIDGEBIOPHARMAINC from our database of 13F filers, detailed in the table below. The first column indicates the name of each of the funds holding BRIDGEBIOPHARMAINC, with a link to that fund's top holdings. The next columns indicate the amount of BRIDGEBIOPHARMAINC stock held by each of the funds holding BRIDGEBIOPHARMAINC, followed by the BRIDGEBIOPHARMAINC position size held by the fund, and lastly the date of the quarterly filing period the data represents. In total, we count 13 funds holding BRIDGEBIOPHARMAINC within the last two filing periods in our coverage universe of 13F filers, with the largest position size having been reported by Advent Capital Management DE. For more details on the positions held by Advent Capital Management DE (or by any of the other funds holding BRIDGEBIOPHARMAINC), click the fund name in the "Holder" column of the funds-holding-BRIDGEBIOPHARMAINC table below.

HolderAmountPosition Size
($ in 1000's)
 As of
Advent Capital Management DE $60,602 12/31/2023
     CONV60,644,000$60,602 12/31/2023
Context Capital Management LLC $21,501 12/31/2023
     NOTE 225,083$21,368 12/31/2023
     NOTE 2110$133 12/31/2023
683 Capital Management LLC $17,821 12/31/2023
     NOTE 214,750,000$17,821 12/31/2023
Mackay Shields LLC $17,491 12/31/2023
     NOTE 214,449,000$17,491 12/31/2023
Segantii Capital Management Ltd $8,582 12/31/2023
     NOTE 210,000,000$8,582 12/31/2023
SSI Investment Management LLC $7,527 12/31/2023
     NOTE 24,751,000$5,727 12/31/2023
     NOTE 22,125,000$1,800 12/31/2023
Verition Fund Management LLC $4,863 12/31/2023
     NOTE 25,709$4,863 12/31/2023
Capstone Investment Advisors LLC $1,704 12/31/2023
     NOTE 22,000,000$1,704 12/31/2023
Aviva PLC $1,210 12/31/2023
     NOTE 21,000,000$1,210 12/31/2023
Shenkman Capital Management Inc. $913 12/31/2023
     NOTE 2750,000$913 12/31/2023
DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main $380 12/31/2023
     NOTE 2450,000$380 12/31/2023
First Hawaiian Bank $102 03/31/2024
     NOTE 295,000$102 03/31/2024
Fox Hill Wealth Management $79 03/31/2024
     NOTE 274,000$79 03/31/2024
Aurum Wealth Management Group LLC13,000$11 03/31/2024
     NOTE 213,000$11 03/31/2024

Funds Holding BRIDGEBIOPHARMAINC | www.HoldingsChannel.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in Holdings Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent. Contact Holdings Channel; Meet Our Editorial Staff.